Navigation Links
Regulus Therapeutics and Collaborators Publish New Pre-Clinical Data on microRNA-33 Demonstrating Key Role in Cholesterol Homeostasis and Fatty Acid Metabolism
Date:10/20/2011

ts the benefits of modulating miR-33a/b and their downstream metabolic pathways."

The Nature paper, "Inhibition of miR-33a/b in non-human primates raises plasma HDL cholesterol and reduces VLDL triglycerides," showed that systemic delivery of an anti-miR targeting both miR-33a and miR-33b in non-human primates increased hepatic miR-33 target gene expression and induced a sustained increase in plasma HDL-C over the 12-week study. In the study protocol, six animals per group received anti-miR-33 via subcutaneous injection at a clinically relevant dose of five mg/kg or a mismatch control. The anti-miR or control were formulated in saline, and administered twice weekly for the first two weeks, and then weekly for the remainder of the 12-week study.  Results showed a maximal HDL-C increase of 50% after eight weeks that was sustained throughout the remainder of the study. Anti-miR-33a/b treatment in this model also increased the expression of miR-33 target genes involved in fatty acid oxidation resulting in suppressed triglyceride levels, a finding not previously observed in mice. The decrease in triglycerides was apparent after four weeks and reached a maximum reduction of 50%.  This pre-clinical study was the first to demonstrate that inhibiting miR-33a/b has a profound and sustained effect on both circulating HDL-C and plasma triglyceride levels.

Ryan Temel, Ph.D., assistant professor at Wake Forest Baptist Medical Center, said, "anti-miR-33a/b has the potential to treat multiple aspects of metabolic syndrome which is a group of risk factors that increase the risk for coronary artery disease, stroke, and type 2 diabetes."

Multiple studies have demonstrated that miR-33a/b strongly represses the cholesterol transporter ABCA1, resulting in decreased generation of HDL-C and reverse cholesterol transport (Rayner et al., J Clin Invest. 2011) as well as key enzymes involved in the oxidation of fatty acid resulting in the acc
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment
2. Webcast Alert: Regulus Therapeutics, Alnylam Pharmaceuticals and Isis Pharmaceuticals Announce New Nature Publication on miR-21 Conference Call
3. United Therapeutics Corporation to Announce Third Quarter 2011 Financial Results Before Market Open on Thursday, October 27, 2011
4. Systemic Lupus Erythematosus Therapeutics (SLE) - Pipeline Assessment and Market Forecasts to 2018
5. Influenza Vaccines Therapeutics - Pipeline Assessment and Market Forecasts to 2018
6. ReportsnReports: Depression Therapeutics Market to Reach $10.9 Billion by 2018
7. Shield Therapeutics Initiates AEGIS 1 and AEGIS 2 Phase 3 Studies of ST10
8. United Therapeutics Announces Proposed Private Offering of $210 Million of Convertible Senior Notes and Authorization of Stock Repurchase Program
9. United Therapeutics Subsidiary Enters Into Contract With National Institutes of Health for Award of up to $45 Million to Support Glycobiology Antiviral Program
10. Kylin Therapeutics Receives Notice of Allowance for Second U.S. Patent Covering Delivery of Therapeutic RNA and pRNAi Technology
11. Orexigen® Therapeutics Announces Multiple Contrave® Data Presentations at the 29th Annual Scientific Meeting of The Obesity Society
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Schaumburg, IL (PRWEB) February 26, 2015 ... to its gauging line by expanding its Length Gauge ... and ACANTO gauges. , Specifically, HEIDENHAIN’s pencil ... an improved force specification. Two new 1Vpp, 12mm ... for lower force applications. One is a variant with ...
(Date:2/26/2015)... Regis Technologies announced new potent ... drug substances. , Regis Technologies is proud to announce ... Compound Suite (PCS) for 2015. , Regis is a ... facility in Morton Grove, Illinois. The PCS addition will ... up to about one kilogram per batch. , ...
(Date:2/26/2015)... 2015  Spark Therapeutics (NASDAQ: ONCE ) ... participate in the Cowen and Company Health Care Conference ... at the Boston Marriott Copley Place. To ... from the Cowen conference, please visit the "Upcoming Events" ... Spark Therapeutics website at www.sparktx.com .  A replay ...
(Date:2/25/2015)... /CNW/ - Radient Technologies Inc. (TSX-V: RTI) (the "Corporation") announced ... the third quarter of its fiscal year ended March ... Analysis, and the CEO & CFO certifications for the ... are available on www.SEDAR.com . ... is also pleased to announce the appointment of Prakash ...
Breaking Biology Technology:Accuracy and Versatile Gauging Go Hand in Hand at HEIDENHAIN 2Regis Extends cGMP Services to Oncology Market 2Spark Therapeutics to Participate in the 35th Annual Cowen and Company Health Care Conference 2Radient Technologies Inc. Releases Third Quarter Results and Appoints New Interim CFO 2
... University of Oregon physicists have successfully landed a one-two ... liquid helium and then dosing its perimeter with a ... to a near standstill. The findings, published in ... processing that exploits special quantum properties and in precision-measurements ...
... Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) will ... in London on Wednesday, June 24, 2009 at 10:30 a.m. ... and chief executive officer of Amylin Pharmaceuticals, will provide a ... session will be webcast, and a recording will be made ...
... June 17 MedNet Solutions, a global life sciences ... today unveiled ENLIGHTEN(TM) as the new name ... also announced multiple new and improved technology tools focused ... , , "The word ,enlighten, means ,to give ...
Cached Biology Technology:MedNet Solutions Unveils New Naming and Functionality for its Flagship EDC/eClinical Offering 2
(Date:2/5/2015)... SAN FRANCISCO , January 28, 2015 ... Camera Market Analysis, Size And Segment Forecasts To 2020 ... The global IR camera market is expected to reach ... study by Grand View Research, Inc. IR cameras help ... injuries, and are expected to witness surging demand in ...
(Date:2/5/2015)... Jan. 30, 2015  It is gratifying to see ... potential for genomic science as a means to better ... and treatment.  I was honored to participate in today,s ... medicine program. Since the 1980s my ... genomics—from the first sequenced genome of a free living ...
(Date:1/22/2015)... , Jan. 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ... in general the State of Washington,s ... a new enrollment and central issuance system for driver,s licenses ... The project planning and development will start in January ...
Breaking Biology News(10 mins):IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Valid USA Signs Contract For Washington Driver's License Issuance 2
... Queen's University study of fruit flies that may revolutionize the ... by a widely-prescribed drug known to cause birth defects. ... treat psoriasis, ectopic pregnancies, rheumatoid arthritis, and lupus, lasts a ... children from women who have it in their systems. The ...
... gene therapy technique that has shown promise in skin disease ... dystrophy, according to a new study by researchers at Stanford ... be published online in the Proceedings of the National Academy ... gene therapy to introduce a healthy copy of the gene ...
... University School of Medicine report in a new study that ... production of myelin, the fatty insulation around nerve cells that ... study, published in the September 1, 2005, issue of the ... system diseases such as multiple sclerosis, which are associated with ...
Cached Biology News:Fruit fly research set to revolutionize study of birth defects 2Gene therapy for muscular dystrophy fixes frail muscle cells in animal model, Stanford study finds 2Gene therapy for muscular dystrophy fixes frail muscle cells in animal model, Stanford study finds 3Scientists discover the molecular switch for nerve cells' insulating jelly rolls 2
... The membrane filters suitable for use in the ... top of each filter, in a specially designed ... special pleating of the band of membrane filter ... dispensed. The shape of the sealed band guarantees ...
...
...
... The model 55S Rocking Shaker provides ... and blotted membranes. The very slow ... degree of tilt provide a gentle ... over gels and blotted membranes to ...
Biology Products: